Is Atossa Therapeutics a good stock to buy?

Is Atossa Therapeutics a good stock to buy?

If you are looking for stocks with good return, Atossa Therapeutics Inc can be a profitable investment option. Atossa Therapeutics Inc quote is equal to 1.530 USD at 2022-01-07. ... With a 5-year investment, the revenue is expected to be around +173.51%. Your current $100 investment may be up to $273..

Is Atossa Genetics a buy?

Maxim Group is very positive about ATOS and gave it a "Buy" rating on ....Predicted Opening Price for Atossa Genetics Inc. of Monday, Decem.

Fair opening price Decem	Current price
$1.92	$1.97 (Overvalued)

Is the Atossa therapeutic?

About Atossa Therapeutics Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to develop innovative medicines in oncology and infectious diseases with a current focus on breast cancer and COVID-19. For more information, please visit www.atossatherapeutics.com.

Why is Atossa stock going up?

Atossa Therapeutics ( ATOS -4.74% ) has been a top-performing biotech stock rising more than this year. Successful results from a mid-stage clinical trial with a potential new breast cancer treatment propelled the stock 61% higher last week and investors want to know if it can go any higher.

Will Bionano Genomics stock go up?

Will Bionano Genomics stock price grow / rise / go up? Yes. The BNGO stock price can go up from 2.760 USD to 7.482 USD in one year.

Why did Atos stock drop so much?

Shares in Atos SE traded sharply lower in early trading on Monday after the French IT company cut its 2021 financial targets on negative growth in the second quarter. ... The company set a new operating margin target of about 6%, down from a previous margin range of between 9.4% and 9.8%, it said.

Why did Atossa stock drop today?

Shares of Atossa Therapeutics (NASDAQ: ATOS) were tumbling 22.8% as of 11:36 a.m. EDT on Wednesday. The decline came after the company announced final results from its phase 2 clinical study evaluating oral endoxifen in treating breast cancer with administration between diagnosis and surgery.

Why did Atos stock drop?

Shares in Atos SE traded sharply lower in early trading on Monday after the French IT company cut its 2021 financial targets on negative growth in the second quarter. ... The company set a new operating margin target of about 6%, down from a previous margin range of between 9.4% and 9.8%, it said.

What is Atossa therapeutics working on?

About Atossa Therapeutics Inc The Company is focused on discovering and developing medicines for breast cancer and Covid-19. Its Covid-19 drugs under development, including the AT-H201 program, is for severely ill patients on ventilators, and AT-301 COVID-19 is a nasal spray.

What does Atossa therapeutics do?

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current focus on breast cancer and COVID-19. For more information, please visit www.atossatherapeutics.com.